Bladder cancer in Poland
Journal Title: Postępy Nauk Medycznych - Year 2012, Vol 25, Issue 4
Abstract
<b>Introduction. </b>Bladder cancer (BCa) is 3<sup>rd</sup> most common cancer in men and 15<sup>th</sup> in women in Poland. The costs of bladder cancer treating from diagnosis until the death of patient is highest among all cancers. Prolonged time from the moment of first symptoms occurrence to the diagnosis of BCa probably negatively influent treatment results. The lack of evidence concerning the length of time from first BCa symptoms occurrence to diagnosis in Poland inspired us to investigate this problem.<br><b>Matherial and methods.</b> The data of 576 patients (pts) treated due to primary BCa in 2003-2009 in our department and in 2009 in Department of Urology Holly Cross Oncological Centre; Clinical Dep. of Urology in Collegium Medicum in Bydgoszcz and in Dep. of Urology Biziel’s Hospital in Bydgoszcz.<br><b>Results.</b> Non-muscle invasive bladder cancer(NMIBC) was diagnosed in 444 (77%) pts while muscle invasive bladder cancer(MIBC) in 132 (23%) pts. Hematuria was the main symptom of BCa in 410 (71%) pts. Other symptoms like dysuria, urinary retention, pain, biochemical features of renal insufficiency or anemia were primary symtoms in 62 (11%) pts. In 104 (18%) pts BCa was diagnosed incidentally. Median time from first symptoms occurrence to diagnosis for NMIBC of low, medium and high groups of progression and recurrence were 60; 60 and 90 days respectively. For pst diagnosed with MIBC it was 90 days. In 181 (41%) NMIBC pts and 78 (59%) MIBC pts BCa was diagnosed after 12 weeks since first symptoms. 52 (11,7%) NMIBC pts and 35 (26,5%) MIBC pts were diagnosed with BCa after 6 months since first symptoms occurrence.<br><b>Conclusions.</b> The time passing since first symptoms of BCa reveled until the final diagnosis in Poland is definitely too long.
Authors and Affiliations
Michał Skrzypczyk, Gerard Grothuss, Jakub Dobruch, Piotr Chłosta, Andrzej Borówka
Badania wieloośrodkowe z udziałem Kliniki Kardiologii CMKP – jak zmieniły leczenie ostrych zespołów wieńcowych
Choroby układu krążenia, a w tym przede wszystkim choroba wieńcowa i jej najgroźniejsze stadium zawał serca, są podstawowymi przyczynami zgonu w rozwiniętych populacjach. Zasady współczesnego leczenia ostrych zespołów wi...
Leczenie złamań końca dalszego kości promieniowej u osób w wieku podeszłym
Złamania dalszego końca kości promieniowej stanowią około 30% wszystkich złamań u pacjentów powyżej 50 roku życia. Pierwszorzędowym celem leczenia tych złamań jest zachowanie funkcji ręki i przedramienia. Agresywność lec...
Frequency of the malignant neoplasms in population commencing renal replacement therapy (RRT) in the years 2001-2015 – one-unit experience
Introduction. The incidence of malignant neoplasms in population of patients initiatingrenal replacement therapy (RRT) is rising last years, which is related to the aging ofgeneral population and to the increasing availa...
Acute myeloid leukemia during pregnancy. A case report and review of the literature
Malignant neoplasms are estimated to occur in about 1 of 1000 pregnancies and leukemias complicate as many as 1 of every 75 000-100 000 pregnancies. Among leukemias, acute myeloid leukemia predominates and due to its agg...
Carcinoma cuniculatum of the larynx – case report
Laryngeal cancer is the most common neoplasm of the head and neck region. Squamous cell cancer (SCC) accounts for more than 95% of all cases of laryngeal cancer. Carcinoma cuniculatum is a well-differentiated, low-grade...